Jack W. Schuler

Insider Reports History

Reporting-owner location: Lake Bluff, IL
Latest reporting-owner signature: /s/ Robin H. Cowie as Attorney-in-Fact for Jack Schuler
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jack W. Schuler

Form 4 holding Emeritus Director, 10%+ Owner

BIODESIX INC

Security class: Common Stock
Shares / value: 1,800,000
Estimated value: $40,590,000
Report date: 12 Aug 2026
Price: $22.55
Ownership: By Jack W. Schuler 2026 GRAT

Form 4 holding Emeritus Director, 10%+ Owner

BIODESIX INC

Security class: Common Stock
Shares / value: 555,810
Estimated value: $13,598,503
Report date: 12 Aug 2026
Price: $24.47
Ownership: By Jack W. Schuler Living Trust

Form 4 holding Director, 10%+ Owner

Accelerate Diagnostics, Inc

Security class: Common Stock
Shares / value: 8,310,388
Estimated value: $13,047,309
Report date: 03 Dec 2024
Price: $1.57
Ownership: By Jack W. Schuler Living Trust

Form 4 holding Emeritus Director, 10%+ Owner

BIODESIX INC

Security class: Common Stock
Shares / value: 750,000
Estimated value: $5,100,450
Report date: 23 Jan 2026
Price: $6.80
Ownership: By Jack W. Schuler 2025 GRAT

Form 4 holding 10%+ Owner

Aspira Women's Health Inc.

Security class: Common Stock
Shares / value: 4,046,051
Estimated value: $1,820,722
Report date: 05 Jun 2026
Price: $0.4500
Ownership: By Jack W. Schuler Living Trust

Form 4 holding 10%+ Owner

SOLENO THERAPEUTICS INC

Security class: Common Stock
Shares / value: 36,595
Estimated value: $1,335,180
Report date: 09 Dec 2022
Price: $36.49
Ownership: By Jack W. Schuler Living Trust

Form 4 holding 10%+ Owner

Aspira Women's Health Inc.

Security class: Warrant (Right to Buy)
Shares / value: 300,000
Estimated value: $120,000
Report date: 05 Jun 2026
Price: $0.4000
Ownership: By Jack W. Schuler Living Trust
Underlying class: Common Stock, par value $0.001
Underlying amount: 300,000

Form 4 holding Director, 10%+ Owner

Accelerate Diagnostics, Inc

Security class: Common Stock
Shares / value: 20,225
Estimated value: $31,753
Report date: 03 Dec 2024
Price: $1.57
Ownership: Direct

Form 4 holding Director, 10%+ Owner

Accelerate Diagnostics, Inc

Security class: Restricted Stock Units
Shares / value: 18,947
Estimated value: $16,673
Report date: 28 Jun 2024
Price: $0.8800
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding 10%+ Owner

YIELD10 BIOSCIENCE, INC.

Security class: Common Stock
Shares / value: 63,789
Estimated value: $12,758
Report date: 20 Dec 2023
Price: $0.2000
Ownership: By Jack W. Schuler Living Trust

Form 4 holding Director, 10%+ Owner

Accelerate Diagnostics, Inc

Security class: Common Stock
Shares / value: 5,497
Estimated value: $8,630
Report date: 03 Dec 2024
Price: $1.57
Ownership: By Spouse

Form 4 holding 10%+ Owner

Aspira Women's Health Inc.

Security class: Warrant (Right to Buy)
Shares / value: 6,536
Estimated value: $2,614
Report date: 05 Jun 2026
Price: $0.4000
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,536

Form 4 holding 10%+ Owner

Aspira Women's Health Inc.

Security class: Common Stock
Shares / value: 6,536
Estimated value: $2,549
Report date: 05 Jun 2026
Price: $0.3900
Ownership: Direct

Form 4 holding Director, 10%+ Owner

Accelerate Diagnostics, Inc

Security class: Common Stock Warrants (right to buy)
Shares / value: 2,716,763
Estimated value
Report date: 20 May 2024
Price
Ownership: By Jack W. Schuler Living Trust
Underlying class: Common Stock
Underlying amount

Form 4 holding 10%+ Owner

YIELD10 BIOSCIENCE, INC.

Security class: Common Stock Warrants
Shares / value: 765,000
Estimated value
Report date: 15 Aug 2023
Price
Ownership: By Jack W. Schuler Living Trust
Underlying class: Common Stock
Underlying amount

Form 4 holding 10%+ Owner

Aspira Women's Health Inc.

Security class: Senior Secured Convertible Note due 2030
Shares / value: $200,000
Estimated value
Report date: 06 Mar 2025
Price
Ownership: By Jack W. Schuler Living Trust
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Jack W. Schuler

4 BDSX

BIODESIX INC

Report period: 12 Aug 2026
Transactions: 1
Transaction value: +$366,992
Accepted by SEC: 13 Aug 2026, 17:22
Role: Emeritus Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 10 Aug 2026
Transactions: 2
Transaction value: +$665,940
Accepted by SEC: 12 Aug 2026, 17:55
Role: Emeritus Director, 10%+ Owner
Next action: Open filing details

4 AWHL

Aspira Women's Health Inc.

Report period: 05 Jun 2026
Transactions: 2
Transaction value: +$100,000
Accepted by SEC: 09 Jun 2026, 16:53
Role: 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 23 Jan 2026
Transactions: 2
Transaction value: +$1,180,736
Accepted by SEC: 27 Jan 2026, 09:29
Role: Emeritus Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 22 Jan 2026
Transactions: 1
Transaction value: +$903,561
Accepted by SEC: 26 Jan 2026, 09:28
Role: Emeritus Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 19 Sep 2025
Transactions: 1
Transaction value: +$999,997
Accepted by SEC: 23 Sep 2025, 09:29
Role: Director, 10%+ Owner
Next action: Open filing details

4 AWHL

Aspira Women's Health Inc.

Report period: 17 Sep 2025
Transactions: 2
Transaction value: +$500,000
Accepted by SEC: 19 Sep 2025, 17:26
Role: 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 17 Sep 2025
Transactions: 2
Transaction value: +$111,425
Accepted by SEC: 19 Sep 2025, 10:31
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 29 Aug 2025
Transactions: 1
Transaction value: +$1,500,000
Accepted by SEC: 03 Sep 2025, 16:42
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 16 May 2025
Transactions: 2
Transaction value: +$1,316,624
Accepted by SEC: 20 May 2025, 16:11
Role: Director, 10%+ Owner
Next action: Open filing details

4 AWHL

Aspira Women's Health Inc.

Report period: 06 Mar 2025
Transactions: 1
Transaction value: +$200,000
Accepted by SEC: 10 Mar 2025, 17:05
Role: 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 03 Dec 2024
Transactions: 1
Transaction value: -$314,000
Accepted by SEC: 03 Dec 2024, 20:46
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 21 Nov 2024
Transactions: 1
Transaction value: +$122,840
Accepted by SEC: 22 Nov 2024, 12:30
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 20 Nov 2024
Transactions: 1
Transaction value: +$234,000
Accepted by SEC: 21 Nov 2024, 15:30
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 05 Nov 2024
Transactions: 1
Transaction value: +$136,585
Accepted by SEC: 06 Nov 2024, 15:16
Role: Director, 10%+ Owner
Next action: Open filing details

4 AWHL

Aspira Women's Health Inc.

Report period: 09 Jul 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 11 Jul 2024, 17:15
Role: 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 28 Jun 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 01 Jul 2024, 18:30
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 29 May 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 30 May 2024, 16:25
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 21 May 2024
Transactions: 4
Transaction value: $0
Accepted by SEC: 23 May 2024, 19:14
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 20 May 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 22 May 2024, 19:03
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 20 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 21 May 2024, 18:59
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 05 Apr 2024
Transactions: 1
Transaction value: +$100,004
Accepted by SEC: 09 Apr 2024, 19:35
Role: Director, 10%+ Owner
Next action: Open filing details

4 AWHL

Aspira Women's Health Inc.

Report period: 26 Jan 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 18 Jun 2024, 16:12
Role: 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 23 Jan 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 25 Jan 2024, 16:11
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 01 Jan 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Jan 2024, 16:18
Role: Director, 10%+ Owner
Next action: Open filing details

YIELD10 BIOSCIENCE, INC.

Report period: 20 Dec 2023
Transactions: 1
Transaction value: -$7,200
Accepted by SEC: 17 May 2024, 15:58
Role: 10%+ Owner
Next action: Open filing details

YIELD10 BIOSCIENCE, INC.

Report period: 19 Dec 2023
Transactions: 1
Transaction value: -$7,430
Accepted by SEC: 20 Dec 2023, 11:13
Role: 10%+ Owner
Next action: Open filing details

YIELD10 BIOSCIENCE, INC.

Report period: 08 Dec 2023
Transactions: 1
Transaction value: -$8,320
Accepted by SEC: 11 Dec 2023, 12:49
Role: 10%+ Owner
Next action: Open filing details

YIELD10 BIOSCIENCE, INC.

Report period: 04 Oct 2023
Transactions: 3
Transaction value: -$27,530
Accepted by SEC: 06 Oct 2023, 20:04
Role: 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 21 Aug 2023
Transactions: 3
Transaction value: +$216,510
Accepted by SEC: 23 Aug 2023, 18:56
Role: Director, 10%+ Owner
Next action: Open filing details

YIELD10 BIOSCIENCE, INC.

Report period: 15 Aug 2023
Transactions: 2
Transaction value: +$497,250
Accepted by SEC: 10 Oct 2023, 16:41
Role: 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 03 Aug 2023
Transactions: 1
Transaction value: +$16,183,000
Accepted by SEC: 11 Aug 2023, 17:34
Role: Director, 10%+ Owner
Next action: Open filing details

4 AWHL

Aspira Women's Health Inc.

Report period: 24 Jul 2023
Transactions: 1
Transaction value: +$499,950
Accepted by SEC: 25 Jul 2023, 17:39
Role: 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 28 Jun 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Jun 2023, 17:57
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 09 Jun 2023
Transactions: 2
Transaction value: +$40,380,432
Accepted by SEC: 20 Jun 2023, 16:10
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 31 May 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 01 Jun 2023, 20:29
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 30 May 2023
Transactions: 2
Transaction value: +$36,156
Accepted by SEC: 01 Jun 2023, 15:00
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 29 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Jun 2023, 18:26
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 25 May 2023
Transactions: 1
Transaction value: +$71,280
Accepted by SEC: 30 May 2023, 15:03
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 24 May 2023
Transactions: 1
Transaction value: +$43,980
Accepted by SEC: 26 May 2023, 15:00
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 23 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 25 May 2023, 18:21
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 23 May 2023
Transactions: 1
Transaction value: +$65,066
Accepted by SEC: 25 May 2023, 15:00
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 22 May 2023
Transactions: 1
Transaction value: +$32,529
Accepted by SEC: 24 May 2023, 15:47
Role: Director, 10%+ Owner
Next action: Open filing details

YIELD10 BIOSCIENCE, INC.

Report period: 05 May 2023
Transactions: 2
Transaction value: +$1,999,997
Accepted by SEC: 09 May 2023, 08:11
Role: 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 31 Jan 2023
Transactions: 1
Transaction value: +$24,100
Accepted by SEC: 01 Feb 2023, 12:03
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 27 Jan 2023
Transactions: 1
Transaction value: +$125,430
Accepted by SEC: 31 Jan 2023, 12:06
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 03 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jan 2023, 15:31
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 01 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Jan 2023, 17:20
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 16 Dec 2022
Transactions: 1
Transaction value: +$17,000
Accepted by SEC: 20 Dec 2022, 15:30
Role: Director, 10%+ Owner
Next action: Open filing details

4/A BDSX

BIODESIX INC

Report period: 15 Dec 2022
Transactions: 1
Transaction value: +$16,476
Accepted by SEC: 31 Jan 2023, 12:00
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 14 Dec 2022
Transactions: 1
Transaction value: +$312,945
Accepted by SEC: 16 Dec 2022, 15:30
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 13 Dec 2022
Transactions: 1
Transaction value: +$106,529
Accepted by SEC: 15 Dec 2022, 15:30
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 12 Dec 2022
Transactions: 1
Transaction value: +$148,380
Accepted by SEC: 14 Dec 2022, 15:30
Role: Director, 10%+ Owner
Next action: Open filing details

4 SLNO

SOLENO THERAPEUTICS INC

Report period: 09 Dec 2022
Transactions: 1
Transaction value: -$9,100
Accepted by SEC: 15 May 2023, 16:04
Role: 10%+ Owner
Next action: Open filing details

YIELD10 BIOSCIENCE, INC.

Report period: 05 Dec 2022
Transactions: 12
Transaction value: -$153,087
Accepted by SEC: 09 May 2023, 08:10
Role: 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 21 Nov 2022
Transactions: 1
Transaction value: +$10,000,000
Accepted by SEC: 21 Nov 2022, 17:03
Role: Director, 10%+ Owner
Next action: Open filing details

4 SLNO

SOLENO THERAPEUTICS INC

Report period: 13 Oct 2022
Transactions: 30
Transaction value: -$465,344
Accepted by SEC: 15 May 2023, 16:00
Role: 10%+ Owner
Next action: Open filing details

YIELD10 BIOSCIENCE, INC.

Report period: 06 Oct 2022
Transactions: 30
Transaction value: -$456,198
Accepted by SEC: 09 May 2023, 08:09
Role: 10%+ Owner
Next action: Open filing details

4 AWHL

Aspira Women's Health Inc.

Report period: 25 Aug 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 29 Aug 2022, 17:37
Role: 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 15 Aug 2022
Transactions: 2
Transaction value: -$49,905,000
Accepted by SEC: 16 Aug 2022, 21:58
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 09 Aug 2022
Transactions: 1
Transaction value: +$9,500,000
Accepted by SEC: 10 Aug 2022, 17:52
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 05 Aug 2022
Transactions: 1
Transaction value: +$38,655,000
Accepted by SEC: 09 Aug 2022, 16:14
Role: Director, 10%+ Owner
Next action: Open filing details

4 SLNO

SOLENO THERAPEUTICS INC

Report period: 02 Aug 2022
Transactions: 18
Transaction value: -$487,962
Accepted by SEC: 14 Oct 2022, 19:11
Role: 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 17 Jun 2022
Transactions: 1
Transaction value: +$1,750,000
Accepted by SEC: 22 Jun 2022, 21:16
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 31 May 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Jun 2022, 16:22
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 24 May 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 26 May 2022, 16:15
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 07 Apr 2022
Transactions: 1
Transaction value: +$5,000,000
Accepted by SEC: 11 Apr 2022, 16:35
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 18 Jan 2022
Transactions: 1
Transaction value: +$165,133
Accepted by SEC: 20 Jan 2022, 15:23
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 13 Jan 2022
Transactions: 2
Transaction value: +$524,442
Accepted by SEC: 18 Jan 2022, 15:22
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 10 Jan 2022
Transactions: 1
Transaction value: +$196,281
Accepted by SEC: 12 Jan 2022, 15:32
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 04 Jan 2022
Transactions: 1
Transaction value: +$49,300
Accepted by SEC: 06 Jan 2022, 15:09
Role: Director, 10%+ Owner
Next action: Open filing details

4/A BDSX

BIODESIX INC

Report period: 30 Dec 2021
Transactions: 1
Transaction value: +$9,999,998
Accepted by SEC: 31 Jan 2022, 05:02
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 30 Dec 2021
Transactions: 1
Transaction value: +$4,935
Accepted by SEC: 04 Jan 2022, 15:16
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 28 Dec 2021
Transactions: 2
Transaction value: +$276,809
Accepted by SEC: 30 Dec 2021, 15:17
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 20 Dec 2021
Transactions: 1
Transaction value: +$257,979
Accepted by SEC: 22 Dec 2021, 14:41
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 17 Dec 2021
Transactions: 1
Transaction value: +$369,152
Accepted by SEC: 21 Dec 2021, 14:37
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 16 Dec 2021
Transactions: 1
Transaction value: +$92,000
Accepted by SEC: 20 Dec 2021, 14:39
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 15 Dec 2021
Transactions: 1
Transaction value: +$74,679
Accepted by SEC: 17 Dec 2021, 14:34
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 29 Nov 2021
Transactions: 1
Transaction value: +$5,000,000
Accepted by SEC: 30 Nov 2021, 12:48
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 22 Nov 2021
Transactions: 1
Transaction value: +$247,874
Accepted by SEC: 24 Nov 2021, 14:29
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 22 Nov 2021
Transactions: 1
Transaction value: +$126,756
Accepted by SEC: 24 Nov 2021, 13:51
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 19 Nov 2021
Transactions: 1
Transaction value: +$295,052
Accepted by SEC: 23 Nov 2021, 14:52
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 19 Nov 2021
Transactions: 1
Transaction value: +$390,186
Accepted by SEC: 23 Nov 2021, 11:44
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 18 Nov 2021
Transactions: 1
Transaction value: +$605,509
Accepted by SEC: 22 Nov 2021, 15:37
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 18 Nov 2021
Transactions: 1
Transaction value: +$179,502
Accepted by SEC: 22 Nov 2021, 14:27
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 17 Nov 2021
Transactions: 1
Transaction value: +$130,104
Accepted by SEC: 19 Nov 2021, 11:32
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 28 Sep 2021
Transactions: 1
Transaction value: +$318,483
Accepted by SEC: 30 Sep 2021, 15:22
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 27 Sep 2021
Transactions: 1
Transaction value: +$799,500
Accepted by SEC: 29 Sep 2021, 15:42
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 24 Sep 2021
Transactions: 1
Transaction value: +$1,047,490
Accepted by SEC: 28 Sep 2021, 15:39
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 23 Sep 2021
Transactions: 1
Transaction value: +$150,442
Accepted by SEC: 27 Sep 2021, 18:52
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 19 Aug 2021
Transactions: 1
Transaction value: +$384,440
Accepted by SEC: 23 Aug 2021, 15:00
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 17 Aug 2021
Transactions: 1
Transaction value: +$211,447
Accepted by SEC: 19 Aug 2021, 15:00
Role: Director, 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 13 Aug 2021
Transactions: 1
Transaction value: +$1,739,490
Accepted by SEC: 17 Aug 2021, 14:30
Role: Director, 10%+ Owner
Next action: Open filing details

4 SLNO

SOLENO THERAPEUTICS INC

Report period: 27 Jul 2021
Transactions: 7
Transaction value: -$146,348
Accepted by SEC: 04 Apr 2022, 16:59
Role: 10%+ Owner
Next action: Open filing details

4 BDSX

BIODESIX INC

Report period: 29 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Jul 2021, 18:22
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 20 May 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 24 May 2021, 21:59
Role: Director, 10%+ Owner
Next action: Open filing details

4 SLNO

SOLENO THERAPEUTICS INC

Report period: 07 Dec 2020
Transactions: 26
Transaction value: -$3,902,582
Accepted by SEC: 03 Aug 2021, 18:43
Role: 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 14 May 2020
Transactions: 2
Transaction value: +$352,308
Accepted by SEC: 16 Jul 2021, 17:18
Role: Director, 10%+ Owner
Next action: Open filing details

4 AXDX

Accelerate Diagnostics, Inc

Report period: 23 Jan 2019
Transactions: 2
Transaction value: +$499,173
Accepted by SEC: 05 Oct 2021, 16:01
Role: Director, 10%+ Owner
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Jack W. Schuler

Insider Reports Filed by Jack W. Schuler